@misc{gainor2022clinical,
  title={Clinical characteristics and molecular features of non-small cell lung cancers (NSCLCs) following disease progression on immune checkpoint inhibitors (ICIs).},
  author={Gainor, Justin F and Ravi, Arvind and Awad, Mark M and Holton, Mark and Arniella, Monica and Stewart, Chip and Freeman, Samuel and Leshchiner, Ignaty and Chow, Andrew and Henick, Brian S and others},
  year={2022},
  publisher={American Society of Clinical Oncology}
}

{"_id":"f6hvjuPBM6DZhqdJz","bibbaseid":"gainor-ravi-awad-holton-arniella-stewart-freeman-leshchiner-etal-clinicalcharacteristicsandmolecularfeaturesofnonsmallcelllungcancersnsclcsfollowingdiseaseprogressiononimmunecheckpointinhibitorsicis-2022","author_short":["Gainor, J. F","Ravi, A.","Awad, M. M","Holton, M.","Arniella, M.","Stewart, C.","Freeman, S.","Leshchiner, I.","Chow, A.","Henick, B. S","others"],"bibdata":{"bibtype":"misc","type":"misc","title":"Clinical characteristics and molecular features of non-small cell lung cancers (NSCLCs) following disease progression on immune checkpoint inhibitors (ICIs).","author":[{"propositions":[],"lastnames":["Gainor"],"firstnames":["Justin","F"],"suffixes":[]},{"propositions":[],"lastnames":["Ravi"],"firstnames":["Arvind"],"suffixes":[]},{"propositions":[],"lastnames":["Awad"],"firstnames":["Mark","M"],"suffixes":[]},{"propositions":[],"lastnames":["Holton"],"firstnames":["Mark"],"suffixes":[]},{"propositions":[],"lastnames":["Arniella"],"firstnames":["Monica"],"suffixes":[]},{"propositions":[],"lastnames":["Stewart"],"firstnames":["Chip"],"suffixes":[]},{"propositions":[],"lastnames":["Freeman"],"firstnames":["Samuel"],"suffixes":[]},{"propositions":[],"lastnames":["Leshchiner"],"firstnames":["Ignaty"],"suffixes":[]},{"propositions":[],"lastnames":["Chow"],"firstnames":["Andrew"],"suffixes":[]},{"propositions":[],"lastnames":["Henick"],"firstnames":["Brian","S"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["others"],"suffixes":[]}],"year":"2022","publisher":"American Society of Clinical Oncology","bibtex":"@misc{gainor2022clinical,\n title={Clinical characteristics and molecular features of non-small cell lung cancers (NSCLCs) following disease progression on immune checkpoint inhibitors (ICIs).},\n author={Gainor, Justin F and Ravi, Arvind and Awad, Mark M and Holton, Mark and Arniella, Monica and Stewart, Chip and Freeman, Samuel and Leshchiner, Ignaty and Chow, Andrew and Henick, Brian S and others},\n year={2022},\n publisher={American Society of Clinical Oncology}\n}\n\n","author_short":["Gainor, J. F","Ravi, A.","Awad, M. M","Holton, M.","Arniella, M.","Stewart, C.","Freeman, S.","Leshchiner, I.","Chow, A.","Henick, B. S","others"],"key":"gainor2022clinical","id":"gainor2022clinical","bibbaseid":"gainor-ravi-awad-holton-arniella-stewart-freeman-leshchiner-etal-clinicalcharacteristicsandmolecularfeaturesofnonsmallcelllungcancersnsclcsfollowingdiseaseprogressiononimmunecheckpointinhibitorsicis-2022","role":"author","urls":{},"metadata":{"authorlinks":{}}},"bibtype":"misc","biburl":"https://bibbase.org/network/files/aX4e85mNvLnP28bmF","dataSources":["hky9vNrwc9uGBMQ9h"],"keywords":[],"search_terms":["clinical","characteristics","molecular","features","non","small","cell","lung","cancers","nsclcs","following","disease","progression","immune","checkpoint","inhibitors","icis","gainor","ravi","awad","holton","arniella","stewart","freeman","leshchiner","chow","henick","others"],"title":"Clinical characteristics and molecular features of non-small cell lung cancers (NSCLCs) following disease progression on immune checkpoint inhibitors (ICIs).","year":2022}